$40.10
0.60[1.52%]
At close: Apr 25
$40.10
0[0.00%]
After Hours: 4:00PM EDT
Xenon Pharmaceuticals
(NASDAQ:XENE)Latest News for Xenon Pharmaceuticals Stock (NASDAQ:XENE)
Xenon Pharmaceuticals Stock (NASDAQ: XENE)
Categories: All
Tuesday, April 16, 2024
Friday, April 12, 2024
Wednesday, April 10, 2024
Friday, March 01, 2024
- RBC Capital Maintains Outperform on Xenon Pharmaceuticals, Lowers Price Target to $55Benzinga Newsdesk - Mar 1, 2024, 10:46AM
- Wedbush Maintains Outperform on Xenon Pharmaceuticals, Raises Price Target to $51Benzinga Newsdesk - Mar 1, 2024, 8:41AM
- Needham Maintains Buy on Xenon Pharmaceuticals, Raises Price Target to $62Benzinga Newsdesk - Mar 1, 2024, 8:11AM
Thursday, February 29, 2024
- Xenon Pharmaceuticals Anticipates Having Sufficient Cash To Fund Operations Into 2027Benzinga Newsdesk - Feb 29, 2024, 4:03PM
- Xenon Pharmaceuticals Q4 EPS $(0.64) Beats $(0.76) EstimateBenzinga Newsdesk - Feb 29, 2024, 4:03PM
- Earnings Scheduled For February 29, 2024Benzinga Insights - Feb 29, 2024, 5:15AM
Wednesday, February 28, 2024
Friday, February 16, 2024
Thursday, January 04, 2024
Tuesday, January 02, 2024
Monday, December 18, 2023
Friday, December 08, 2023
Thursday, November 30, 2023
- Why Xenon Pharmaceuticals Stock (XENE) Is Seeing Blue Skies TodayHenry Khederian - Nov 30, 2023, 2:51PM
- Xenon Pharmaceuticals shares are trading higher. The company announced the pricing of its upsized $300 million public offering of 8,461,542 common shares at $32.50 per share.Benzinga Newsdesk - Nov 30, 2023, 12:25PM
- Xenon Pharmaceuticals Prices Its Upsized $300M Public Offering Of 8,461,542 Common Shares At $32.50/ShareBenzinga Newsdesk - Nov 30, 2023, 3:25AM
Wednesday, November 29, 2023
Tuesday, November 28, 2023
Monday, November 27, 2023
- Xenon Pharma's Depression Candidate Shows Positive Signals Of Efficacy, Despite Primary Endpoint Miss: AnalystVandana Singh - Nov 27, 2023, 2:10PM
- Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day SessionLisa Levin - Nov 27, 2023, 1:41PM
- What's Going On With Neurology-Focused Xenon Pharmaceuticals' Stock Today?Vandana Singh - Nov 27, 2023, 11:40AM
- Ituran Location and Control Posts Q3 Results, Joins Crown Castle, Shopify And Other Big Stocks Moving Higher On MondayLisa Levin - Nov 27, 2023, 10:17AM
- Xenon Pharmaceuticals shares are trading higher after the company announced topline results from the Phase 2 proof-of-concept X-NOVA clinical trial of XEN1101 in MDD.Benzinga Newsdesk - Nov 27, 2023, 10:02AM
- Xenon Pharmaceuticals Released Topline Results From Phase 2 X-NOVA Trial Of XEN1101 For Moderate To Severe Major Depressive Disorder, Primary Endpoint Of The Change In The Montgomery-åsberg Depression Rating Scale Not Statistically SignificantBenzinga Newsdesk - Nov 27, 2023, 7:32AM
Friday, November 10, 2023
Thursday, November 09, 2023
Wednesday, November 08, 2023
Tuesday, November 07, 2023
Tuesday, October 24, 2023
Monday, October 09, 2023
Friday, September 22, 2023
Tuesday, September 05, 2023
Tuesday, August 22, 2023
Thursday, August 10, 2023
- Xenon Pharmaceuticals shares are trading higher after the company reported Q2 financial results.Benzinga Newsdesk - Aug 10, 2023, 12:06PM
- Wedbush Reiterates Outperform on Xenon Pharmaceuticals, Maintains $47 Price TargetBenzinga Newsdesk - Aug 10, 2023, 9:40AM
- Needham Reiterates Buy on Xenon Pharmaceuticals, Maintains $50 Price TargetBenzinga Newsdesk - Aug 10, 2023, 5:53AM